Delivery Order SPE2DB20D7059-SPE2DB24FQLC1
Award Date
8/15/24
Potential Completion Date
8/16/24
Potential Value
$71K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $3,233.58 firm-fixed-price delivery order is for the supply of 4,565,699 units of the GARDASIL 9 vaccine syringe (0.5mL) with no set-aside designation. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $12,648.84 firm fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 17, 2024 and did not utilize any set-aside. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and...
This federal contract award, valued at $14,757.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order for the supply of GARDASIL 9 SYRINGE 0.5ML, a critical vaccine product. The contract has a firm fixed price pricing type and an ultimate completion date of June 27, 2024. AmerisourceBergen, through its Corporate Office division, will deliver these medical supplies to support the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,320.14 firm fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corporation's Corporate Office division. The $28,979.57 Firm Fixed Price Delivery Order is for the supply of 4,565,804,807 units of the GARDASIL 9 SYRINGE 0.5ML vaccine. The contract has a completion date of September 16, 2024 and does not utilize a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, leverages its extensive...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of GARDASIL 9 vaccine syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,337.81 firm fixed-price delivery order, awarded on September 18, 2024, has an ultimate completion date of September 19, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $15,941.17 firm fixed-price delivery order is for the supply of 4565795672 GARDASIL 9 syringes (0.5 mL). The contract has an ultimate completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor in the United States, has been awarded numerous federal contracts and Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $17,329.28, is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 28, 2024. The contract is not set aside for any specific business designation. AmerisourceBergen is a major supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,274.75 firm-fixed-price delivery order is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of July 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,568.50 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical commodities, including critical care...